Document Detail


Is a migraine screener useful for pharmacists in community pharmacy to distinguish patients with migraine?
MedLine Citation:
PMID:  20519867     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this study, to clarify the characteristics of a migraine screener that would be useful to pharmacists in community pharmacies, we used the migraine screener to investigate patients with migraine. Diagnosis of migraine was made according to the internal classification of headache disorders 2nd edition (ICHD-II). Eighty patients with migraine (with aura: n=21, without aura: n=59) were divided into a positive group (n=51, 64%) and a negative group (n=29, 36%) based on the results of the migraine screener, which included a 4-item (headache exacerbation in daily performance, nausea, light-sensitivity and hypersensitivity to odors). The positive rate of the migraine screener was 64%. In the positive group, patients had moderate-to-severe migraine attacks in the past 3 months. Moreover, 82% of patients in the positive group reported disturbances in their daily of life due to headache. In the negative group, 41% of patients also reported disturbances in their daily of life. Therefore, pharmacists have to check the influence of headache on daily of life not only in the positive group but also in the negative group. These findings provide useful information to guide pharmacists in community pharmacies when using the screener for migraine to distinguish patients with headache from those with migraine.
Authors:
Masakazu Ishii; Ayumu Nagamine; Yuka Kimura; Atsuko Imagawa; Johji Takahashi; Hajime Hara; Yutaka Masuda; Shino Usami; Yuji Kiuchi
Related Documents :
3551827 - Clinical study evaluating efficacy of praziquantel in clonorchiasis.
17667237 - Ecmo for meconium aspiration syndrome: support for relaxed entry criteria.
1619407 - Migraine aura without headache: transient ischaemic attack or not?
17655717 - Comorbidity of migraine and headache associated with sexual activity.
20827107 - Outcomes in biopsy-proven lupus nephritis: evaluation of 190 white patients from a sing...
10336597 - Association between mast cell chymase genotype and atopic eczema: comparison between pa...
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan     Volume:  130     ISSN:  0031-6903     ISO Abbreviation:  Yakugaku Zasshi     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-03     Completed Date:  2010-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0413613     Medline TA:  Yakugaku Zasshi     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  881-7     Citation Subset:  IM    
Affiliation:
Department of Pathophysiology, School of Pharmacy, Showa University. masakazu@pharm.showa-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Diagnosis, Differential
Female
Humans
Male
Middle Aged
Migraine Disorders / diagnosis*,  drug therapy*
Pharmacies*
Pharmacists*
Questionnaires*
Tryptamines / administration & dosage
Young Adult
Chemical
Reg. No./Substance:
0/Tryptamines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  LC Determination and Pharmacokinetic Study of Hyperoside in Rat Plasma after Intravenous Administrat...
Next Document:  Effect of beta-Cyclodextrin on the Degradation Rate of Amoxicillin in Acidic Solution.